ES2084577T3 - Ensayo, trazadores, inmunogenos y anticuerpos para benzodiazepinas. - Google Patents

Ensayo, trazadores, inmunogenos y anticuerpos para benzodiazepinas.

Info

Publication number
ES2084577T3
ES2084577T3 ES87114982T ES87114982T ES2084577T3 ES 2084577 T3 ES2084577 T3 ES 2084577T3 ES 87114982 T ES87114982 T ES 87114982T ES 87114982 T ES87114982 T ES 87114982T ES 2084577 T3 ES2084577 T3 ES 2084577T3
Authority
ES
Spain
Prior art keywords
tracers
benzodiazepines
immunogens
antibodies
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87114982T
Other languages
English (en)
Inventor
Nai-Yi Wang
Candace Linda Keegan
Daniel Fuelner Heiman
Charles Arthur Flentge
Philip Pei Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2084577T3 publication Critical patent/ES2084577T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates

Abstract

LA PRESENTE INVENCION ESTA DIRIGIDO A UN ENSAYO DE POLARIZACION FLUORESCENTE PARA BENZODIACEPINAS Y SUS METABOLITOS, O VARIOS COMPONENETES NECESARIOS PARA PREPARAR Y LLEVAR A CABO TAL COMO UN ENESAYO Y METODOS DE HACER ESTOS COMPONENETE. ESPECIFICAMENTE, INDICADORES, INMUNOGENOS Y ANTICUERPOS ESTAN DISPUESTOS, TAL COMO METODOS PARA FABRICARLOS. EL ENSAYO ES DIRIGIDO POR LA MEDICION DEL GRADO DE RETENCION POR POLARIZACION DEL FLUORESCENTE RESULTANTE CUANDO UNA MUESTRA MEZCLADA CON ANTISERUM E INDICADOR ES IRRADIADA CON EL PLANO DE LUZ POLARIZADA.
ES87114982T 1986-10-24 1987-10-14 Ensayo, trazadores, inmunogenos y anticuerpos para benzodiazepinas. Expired - Lifetime ES2084577T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92259586A 1986-10-24 1986-10-24

Publications (1)

Publication Number Publication Date
ES2084577T3 true ES2084577T3 (es) 1996-05-16

Family

ID=25447288

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87114982T Expired - Lifetime ES2084577T3 (es) 1986-10-24 1987-10-14 Ensayo, trazadores, inmunogenos y anticuerpos para benzodiazepinas.

Country Status (9)

Country Link
EP (1) EP0264797B1 (es)
JP (1) JPH0660166B2 (es)
KR (1) KR880005101A (es)
AT (1) ATE132974T1 (es)
AU (1) AU604766B2 (es)
CA (1) CA1339439C (es)
DE (1) DE3751673T2 (es)
ES (1) ES2084577T3 (es)
GR (1) GR3019283T3 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148225T3 (es) * 1992-03-30 2000-10-16 Abbott Lab Reactivos y procedimientos que permiten la deteccion y la cuantificacion de la tiroxina en muestras de fluido.
US5352803A (en) * 1992-03-30 1994-10-04 Abbott Laboratories 5(6)-methyl substituted fluorescein derivatives
AU678503B2 (en) * 1993-09-24 1997-05-29 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds and their use as squalene synthetase inhibitors
US5492841A (en) * 1994-02-18 1996-02-20 E. I. Du Pont De Nemours And Company Quaternary ammonium immunogenic conjugates and immunoassay reagents
DE19503320A1 (de) * 1995-02-02 1996-08-08 Boehringer Mannheim Gmbh Neue Benzodiazepinkonjugate
EP0934527B1 (en) * 1996-10-25 2002-07-24 Elimo B.V. Non radioactive receptor assay suitable for quantitative and qualitative analysis of trace amounts of receptor binding analyte
US7160880B1 (en) 1999-05-14 2007-01-09 Cenes Limited Short-acting benzodiazepines
GB9911152D0 (en) * 1999-05-14 1999-07-14 Glaxo Group Ltd Short-acting benzodiazepines
EP1210338A2 (en) * 1999-08-05 2002-06-05 IGT Pharma Inc. 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system
US7026166B2 (en) 2002-01-22 2006-04-11 Chiron Corporation Fluorogenic dyes
US7029918B2 (en) * 2002-01-25 2006-04-18 Roche Diagnostics Operations, Inc. Water-soluble derivatives of lipophilic drugs
US7704756B2 (en) 2003-01-21 2010-04-27 Novartis Vaccines And Diagnostics, Inc. Fluorogenic dyes
PT2081921E (pt) 2006-07-10 2010-12-10 Paion Uk Ltd Sais de benzodiazepina de acção curta e suas formas polimórficas
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA714391B (en) * 1970-07-29 1972-04-26 Hoffmann La Roche Benzodiazepine derivatives
CH538492A (de) * 1970-10-07 1973-06-30 Hoffmann La Roche Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH566324A5 (en) * 1970-10-07 1975-09-15 Hoffmann La Roche 1-Carbamoylalkyl substd. 1,4-benzodiazepin-2-ones prodn - from corresp acids or derivs by reacting with amines, useful as CNS depressants
US4243654A (en) * 1978-09-11 1981-01-06 Syva Company Oxazepam derivatives for immunoassay reagents
AT361492B (de) * 1978-12-18 1981-03-10 Gerot Pharmazeutika Verfahren zur herstellung von neuen 3-hydroxy- 1,4-benzodiazepin-2-onen
US4318846A (en) * 1979-09-07 1982-03-09 Syva Company Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers
EP0218010A3 (en) * 1985-07-10 1988-01-07 Abbott Laboratories Ligand detection method and substituted carboxyfluorescein tracers therefor

Also Published As

Publication number Publication date
DE3751673T2 (de) 1996-08-01
EP0264797A3 (en) 1990-02-07
AU7997587A (en) 1988-04-28
JPH0660166B2 (ja) 1994-08-10
CA1339439C (en) 1997-09-02
KR880005101A (ko) 1988-06-28
ATE132974T1 (de) 1996-01-15
JPS63246666A (ja) 1988-10-13
AU604766B2 (en) 1991-01-03
EP0264797B1 (en) 1996-01-10
EP0264797A2 (en) 1988-04-27
DE3751673D1 (de) 1996-02-22
GR3019283T3 (en) 1996-06-30

Similar Documents

Publication Publication Date Title
EP0254120A3 (en) Immunoassay for opiate alkaloids and their metabolites; tracers, immunogens and antibodies
EP0459387A3 (en) Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit
ES2084577T3 (es) Ensayo, trazadores, inmunogenos y anticuerpos para benzodiazepinas.
PT96029A (pt) Processo para a determinacao de um analito por meio de um sal fracamente soluvel de um heteropoltacido
SE7707837L (sv) Forfarande for framstellning av ett enzymgranulat samt enzymgranulat framstellt medelst forfarandet
ATE40602T1 (de) Immunchemisches messverfahren.
CH640383B (de) Verfahren zur herstellung von staubarmen farbstoff- und optischen aufhellerpraeparaten.
SE7704305L (sv) Forfarande for analys av ett biologiskt vetskeprov
NO163920C (no) Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.
GB1484579A (en) Biological staining technique and mixture thereof
AU7708191A (en) Barbiturate assay, tracers, immunogens and antibodies and kit
ES2035452T3 (es) Procedimiento para la obtencion conjunta de 3-dialquil-aminopropionitrilos, bis-(2-cianoetil)-eteres y en caso deseado etilencianhidrina.
BR8002694A (pt) Processo para a producao de derivados de 4-halo-tiazol e processo para tingimento ou estampagem de substatos organicos sinteticos ou semi-sinteticos, de alto peso molecular, hidrofobicos
ES2056919T3 (es) Anticuerpo monoclonal especifico para la fosfolipasa a2 pancreatica humana.
ES2061686T3 (es) Progreso de epoxidos.
ES2037770T3 (es) Procedimiento para la preparacion de intermediarios para la sintesis de fosfomicina.
EP0201633A3 (en) Substituted anilide compounds and their use
FI882057A0 (fi) Menetelmä polarisoitujen fluoresenssiemissioiden mittaamiseksi
EP0252405A3 (en) 3-methoxy-4-hydroxyphenylglycol fluorescence polarization immunoassay
EP0373508A3 (en) Barbiturate assay, tracers, immunogens and antibodies
ES2147731T3 (es) Haptenos, trazadores, inmunogenos y anticuerpos para inmunoanalisis de deteccion de propoxifeno.
FR2364214A2 (fr) Benzimidazo-(1,2-a)-quinoleines et leur preparation
FI87021B (fi) Foerfarande foer stabilisering av prostataspecifik antigen i naturella matriser och foerfarande foer framstaellning av matriser.
DK146181C (da) Fremgangsmaade til fremstilling af 4-amino-5-chlor-1-phenyl-pyridazon-6
JPS51129288A (en) Sample cell for fluorescence detector

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 264797

Country of ref document: ES